US88034P1093 - ADR
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 31.244B 7.17% | 28.339B -9.30% | 27.752B -2.07% | 28.97B 4.39% | |||||||
EBITDA YoY % growth | 3.718B -18.29% | 4.376B 17.70% | 5.781B 32.11% | 7.914B 36.90% | N/A | N/A | |||||
EBIT YoY % growth | 2.717B -27.08% | 3.216B 18.37% | 4.777B 48.54% | 7.137B 49.40% | N/A | N/A | |||||
Operating Margin | 8.70% | 11.35% | 17.21% | 24.64% | N/A | N/A | |||||
EPS YoY % growth | 2.46 -16.61% | 2.94 19.51% | 3.75 27.55% | 4.49 19.70% | N/A | N/A | N/A |
All data in CNY
Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 1.03 15.53% | |||||||||||
Revenue Q2Q % growth | 6.7B -4.34% | N/A | N/A | N/A | N/A | |||||||
EBITDA Q2Q % growth | 1.744B | |||||||||||
EBIT Q2Q % growth | 1.601B 47.42% |
All data in CNY
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 1.00 9.89% | 0.99 | 0.01 | 1.45% |
Q3 2023 Q2Q % growth | 0.89 3.49% | 0.89 | 0.00 | 0.03% |
Q2 2023 Q2Q % growth | 0.97 53.97% | 0.99 | -0.02 | -2.30% |
Q1 2023 Q2Q % growth | 0.89 64.81% | 0.80 | 0.09 | 11.10% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 6.893B -7.16% | 6.774B | 119M | 1.76% |
Q3 2023 Q2Q % growth | 6.569B -10.81% | 6.369B | 200M | 3.14% |
Q2 2023 Q2Q % growth | 7.286B 5.52% | 7.358B | -72M | -0.98% |
Q1 2023 Q2Q % growth | 7.004B 5.42% | 6.928B | 76M | 1.10% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | -0.71% | 7.58% | 7.69% | 7.56% |
Revenue | -0.07% | 4.41% | 2.33% | 2.38% |